-
MedCity Influencers, Medical Devices
GE Healthcare forms two new partnerships, expands market reach
GE Healthcare signed two new deals that will expand its footprint in the radiotherapy and […]
-
MedCity Influencers, Medical Devices
Sen. Scott Brown talks medical device tax repeal at Covidien
Massachusetts Senator and GOP presidential hopeful Scott Brown told Covidien plc (NYSE:COV) employees that the […]
-
In-home care positioned to play a key role in the consumerization of healthcare
Eddie Peloke, CEO of Workpath, spoke to why in-home care can drive the next stage of this industry-wide movement
-
MedCity Influencers, Medical Devices
Unnecessary stents cost Maryland hospital $1.8M in legal settlement
A Maryland hospital paid $1.8 million to settle allegations that senior leadership failed to properly […]
-
MedCity Influencers, Medical Devices
Covidien announces $2 billion stock repurchase program
Covidien Plc.’s (NYSE:COV) board of directors approved a $2 billion stock repurchase program today. “The […]
-
MedCity Influencers, Medical Devices
Insulin pump hacking not a threat, Medtronic says
Medtronic Inc. (NYSE:MDT) isn’t in an uproar over recent reports of a hacked insulin pump […]
-
MedCity Influencers, Medical Devices
Boston Scientific to spend $37 million on Irish R&D facility
Boston Scientific Corp. (NYSE:BSX) plans to spend $37 million on overseas research and development, this […]
-
MedCity Influencers, Medical Devices
Abbott, Boston Scientific claim 64 percent of U.S. drug-eluting stent market
Abbott Laboratories (NYSE:ABT) and Boston Scientific Corp. (NYSE:BSX) came out as the big players in […]
-
Smith & Nephew realignment plan targets growth in emerging markets
British orthopedic giant Smith & Nephew plc (NYSE:SNN) announced an ambitious plan to realign the […]
-
MedCity Influencers, Medical Devices
St. Jude, Illumina buying back shares
St. Jude Medical Inc. (NYSE:STJ) and Illumina Inc. (NSDQ:ILMN) both announced share repurchase programs this […]
-
Improving health in one of the most complex and costly chronic conditions
Kidney care in the U.S. needs an overhaul. Changing today’s expensive, disconnected care model requires moving from volume to value.
Misha Palecek, Chief Transformation Officer, DaVita Kidney Care
-
MedCity Influencers, Medical Devices
Medtronic taking part in GI Dynamics private placement
Medtronic Inc. (NYSE:MDT) is deepening its commitment to GI Dynamics Inc. by participating in a […]
-
MedCity Influencers, Medical Devices
Medical device maker Covidien expects to add more jobs overseas
Covidien Plc. (NYSE:COV) will likely beef up its overseas workforce, CEO Joe Almeida told attendees […]
-
MedCity Influencers, Medical Devices, Policy
FDA’s 510(k) program should not be scrapped, say Minnesota politicians
Lawmakers from the North Star State are falling in line to oppose one of the […]
-
MedCity Influencers, Medical Devices
Medical device industry user fee talks moving too slowly, says FDA
FDA officials are expressing concern over the slow pace of user fee negotiations with the […]
-
MedCity Influencers, Medical Devices
Premarket review standards updated by FDA
The FDA released a notice yesterday announcing updated, withdrawn and modified standards that the agency […]
-
MedCity Influencers, Medical Devices
Elliott still reshaping Boston Scientific despite upcoming retirement
The shakeup at Boston Scientific (NYSE:BSX) last week proved that while the sheriff may be […]



